Comparison between Piotex Industries IPO and Quest Laboratories IPO.
Piotex Industries IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Quest Laboratories IPO is a SME Bookbuilding proposed to list at NSE SME.
Piotex Industries IPO | Quest Laboratories IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price | Bookbuilding |
Listing At | BSE SME | NSE SME |
Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Shreni Shares Ltd. |
Registrar | Cameo Corporate Services Ltd. | Bigshare Services Pvt.Ltd. |
Market Maker | Spread X Securities Pvt.Ltd. | Rikhav Securities Ltd. |
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | RHP ![]() |
Anchor Investor | Anchor Investor ![]() | |
IPO Allotment URL | IPO Allotment URL ![]() | IPO Allotment URL ![]() |
The total issue size of Piotex Industries IPO is up to ₹13.74 Cr whereas the issue size of the Quest Laboratories IPO is up to ₹40.95 Cr. The final issue price of Piotex Industries IPO is ₹94.00 per share and of Quest Laboratories IPO is ₹97.00 per share.
Piotex Industries IPO | Quest Laboratories IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹93.00 per share | |
Issue Price (Upper) | ₹97.00 per share | |
Issue Price (Final) | ₹94.00 per share | ₹97.00 per share |
Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
Discount (Employee) | ||
Market Lot Size | 1200 shares | 1200 shares |
Fresh Issue Size | 14,61,600 shares | 42,21,600 shares |
Fresh Issue Size (Amount) | up to ₹13.74 Cr | up to ₹40.95 Cr |
OFS Issue Size | 0 shares | 0 shares |
OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Issue Size Total | 14,61,600 shares | 42,21,600 shares |
Issue Size Total (Amount) | up to ₹13.74 Cr | up to ₹40.95 Cr |
Piotex Industries IPO opens on May 10, 2024, while Quest Laboratories IPO opens on May 15, 2024. The closing date of Piotex Industries IPO and Quest Laboratories IPO is May 14, 2024, and May 17, 2024, respectively.
Piotex Industries IPO | Quest Laboratories IPO | |
---|---|---|
Anchor Bid Date | May 14, 2024 | |
Issue Open | May 10, 2024 | May 15, 2024 |
Issue Close | May 14, 2024 | May 17, 2024 |
Basis Of Allotment (Tentative) | May 15, 2024 | May 21, 2024 |
Initiation of Refunds (Tentative) | May 16, 2024 | May 22, 2024 |
Credit of Share (Tentative) | May 16, 2024 | May 22, 2024 |
Listing date (Tentative) | May 17, 2024 | May 23, 2024 |
Anchor Lockin End date 1 | Jun 20, 2024 | |
Anchor Lockin End date 2 | Aug 19, 2024 |
Piotex Industries IPO P/E ratio is 11.14, as compared to Quest Laboratories IPO P/E ratio of 23.03.
Piotex Industries IPO | Quest Laboratories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | Piotex Industries Limited Financial Information (Restated)Piotex Industries Limited's revenue increased by 37.23% and profit after tax (PAT) rose by 4.17% between the financial year ending with March 31, 2024 and March 31, 2023.
| Quest Laboratories Limited Financial Information (Restated)Quest Laboratories Limited's revenue increased by 3.9% and profit after tax (PAT) rose by 22.5% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100.00 | 90.36 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 69.83 | 65.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 11.14 | 23.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹47.97 Cr. | ₹158.96 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 44.99% | 34.03% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 33.20% | 41.86% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.50 | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹8.44 | ₹4.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 33.53% | 34.03% |
In the Piotex Industries IPO Retail Individual Investors (RII) are offered 7,30,800 shares while in Quest Laboratories IPO retail investors are offered 7,30,800 shares. Qualified Institutional Buyers (QIB) are offered in Piotex Industries IPO and 8,31,600 shares in Quest Laboratories IPO.
Piotex Industries IPO | Quest Laboratories IPO | |
---|---|---|
Anchor Investor Reserveration | 12,36,000 shares | |
Market Maker Reserveration | 78,000 shares | 2,28,000 shares |
QIB | 8,31,600 shares | |
NII | 7,30,800 shares | 6,55,200 shares |
RII | 7,30,800 shares | 14,98,800 shares |
Employee | ||
Others | ||
Total | 14,61,600 shares | 42,21,600 shares |
Piotex Industries IPO subscribed 107.44x in total, whereas Quest Laboratories IPO subscribed 85.26x.
Piotex Industries IPO | Quest Laboratories IPO | |
---|---|---|
QIB (times) | 57.20x | |
NII (times) | 115.21x | 184.10x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 93.33x | 57.63x |
Employee (times) | ||
Other (times) | ||
Total (times) | 107.44x | 85.26x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O